Prevalence of Myocardial Scars on CMR After COVID-19 Infection
NCT04636320 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 231
Last updated 2023-03-16
Summary
The aim of this study is to assess the prevalence and arrhythmogenic role of occult myocardial scars on Cardiac Magnetic Resonance (CMR) in a population of patients with history of laboratory-proven symptomatic COVID-19 infection managed without hospitalization, as compared to a population of age- and sex-matched healthy volunteers.
Conditions
- COVID-19
- Virus Disease
Interventions
- DEVICE
-
Contrast-enhanced CMR
Cardiac Magnetic Resonance Imaging (MRI) examinations will be performed at Day 0 visit on clinical systems 1.5 equipped with specific antennas for cardiac imaging. The imaging protocol will last approximately 50 minutes.
- DIAGNOSTIC_TEST
-
Exercise test ECG
A treadmill exercise test with 12 lead ECG monitoring will be performed at M3 visit. Maximum expected enrollment 30 MRI+ patients and 30 healthy volunteers MRI- matched controls.
- BIOLOGICAL
-
Blood sample
A blood sample will be taken at Day 0 visit for COVID-19 serology, hematocrit measurement, ultra-high sensitive troponin test, low grade markers of inflammation, genetic profiling. An other blood sample will be taken at M3 visit for a control COVID-19 serology for 30 healthy volunteers.
- DIAGNOSTIC_TEST
-
Resting 12 lead ECG
A resting 12 lead ECG will be performed at Day 0 visit.
- DIAGNOSTIC_TEST
-
24 hour Holter ECG
A 24 hour Holter ECG will be performed at M3 visit. Maximum expected enrollment 30 MRI+ patients and 30 healthy volunteers MRI- matched controls.
Sponsors & Collaborators
-
Grant Agreement ERC n°715093
collaborator UNKNOWN -
University of Bordeaux
collaborator OTHER -
University Hospital, Bordeaux
lead OTHER
Principal Investigators
-
Hubert COCHET, MD-PhD · University Hospital, Bordeaux
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-06-13
- Primary Completion
- 2022-04-04
- Completion
- 2022-04-04
Countries
- France
Study Locations
More Related Trials
-
Safety and Efficacy of MCG for Diagnosing Coronary Heart Disease
NCT00170027 ·Status: COMPLETED ·Phase: PHASE3
-
Multimodal IMAgery Characterization of Cardiac Damage and Severity After COVID-19 Infection
NCT04753762 ·Status: COMPLETED
-
Manganese-Enhanced Magnetic Resonance Imaging of MyOcardial injuRY in COVID 19 (COVID-19)
NCT04625075 ·Status: COMPLETED
-
French National Observatory Tracking Viral Myocarditis: Mortality, Cardiovascular Events, Sequels on (Magnetic Resonance Imaging) MRI
NCT02717143 ·Status: COMPLETED
-
Myocardial Salvage Assessed by Cardiovascular Magnetic Resonance - Impact on Outcome
NCT00952224 ·Status: COMPLETED
-
Characterization of Myocardial Infarction Scar Using Magnetic Resonance Imaging
NCT05967026 ·Status: UNKNOWN
-
Cardiac Imaging in SARS-CoV-2 (COVID-19)
NCT04403607 ·Status: UNKNOWN
-
Prognostic Value of Myocardial Fibrosis Quantified Using CMR in Patient With Dilated Cardiomyopathy
NCT02352129 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging in Myocarditis
NCT02177630 ·Status: COMPLETED
-
Precision of the Magnetocardiographer for Data Aquision and Analysis.
NCT00170014 ·Status: COMPLETED ·Phase: PHASE3
-
Non-contrast Enhanced Cardiac Magnetic Resonance Normal Values and Imaging Protocols
NCT01728597 ·Status: RECRUITING
-
Role of CMR-FT in Assessment of HCM and Athlete's Heart.
NCT06859827 ·Status: ACTIVE_NOT_RECRUITING
-
Improved Detection of Myocardial Fibrosis: a Cardiovascular Magnetic Resonance Imaging Study
NCT06697509 ·Status: ENROLLING_BY_INVITATION
-
Support for the Resumption of Training of High-level Athletes Post-epidemic COVID-19
NCT04936503 ·Status: COMPLETED ·Phase: NA
-
A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease
NCT04464655 ·Status: RECRUITING
-
Accelerated Stress CMR in Coronary Artery Disease
NCT05221762 ·Status: ACTIVE_NOT_RECRUITING
-
Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability
NCT06047028 ·Status: RECRUITING
-
Image-Based Prediction of Ventricular Tachycardias in Post-Myocarditis Patients: an International Multicenter Case-control Study
NCT06730607 ·Status: RECRUITING
-
Cardiac MRI in Front Line for the Diagnosis of Coronary Artery Disease as the Etiology of Left Ventricular Dysfunction
NCT03231189 ·Status: COMPLETED
-
Cardiac Magnetic Resonance for Diagnosis, Treatment Guidance and Prognosis of Cardiac Masses (CMR)
NCT07335770 ·Status: ENROLLING_BY_INVITATION
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
NCT05164744 ·Status: RECRUITING
-
MAGNetic QRS-Fragmentation in Patients With Myocardial InfarcTion and Moderately RedUceD Ejection Fraction
NCT01972126 ·Status: TERMINATED
-
Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
NCT06409585 ·Status: RECRUITING
-
CMR in Patients With Myocarditis
NCT01962584 ·Status: COMPLETED
-
Efficacy of the CMI Magnetocardiograph in Diagnosing Acute Coronary Syndromes in Patients Presenting With High Risk Unstable Angina.
NCT00169975 ·Status: COMPLETED